HER Family Receptors are Important Theranostic Biomarkers for Cervical Cancer: Blocking Glucose Metabolism Enhances the Therapeutic Effect of HER Inhibitors

Files in this item

This item appears in the following Collection(s)

Search DSpace



Browse

My Account

Statistics